Cookie Policy - To find out more about cookies on this website, see our privacy policy

Cookie Policy

We Help Companies Find New Sales Opportunities

We Help Companies Find New Sales Opportunities

Protherics


Protherics, the biotechnology company with 300 staff at sites in Runcorn, London, Ceredigion, Australia and the US, is to be acquired by BTG for £218m.
19-Sep-2008


Protherics has raised £38m in a share placing to fund the expansion of its biotechnology business, including the acquisition of US-based MacroMed and licensing deals with Glenveigh Pharmaceuticals and Advanced In Vitro Cell Technologies.
05-Jan-2007


Protherics, the biotechnology company developing a new treatment for sepsis, is to invest £10m in research this year.
10-Apr-2006


Protherics has secured a £7.5m equity investment from AstraZeneca, and AZ will also fund a £16m expansion of Protherics' biopharmaceuticals production facilities.
12-Dec-2005


Protherics is seeking financial assistance from the Welsh Assembly to expand its biotechnology-based production plant in Llandysul.
09-Jun-2003


Protherics is to acquire Enact Pharma, the biopharmaceuticals company, for £7.9m, and has also announced plans to raise £3m in a share offer.
06-May-2003


Protherics is selling its computer-aided molecular design business to Tularik of the US for £6.7m.
13-Jul-2001


Protherics has raised £3.1m in a share placing in order to fund the expansion of its pharmaceutical production facilities.
30-Jan-2001